Skip to main content

Animations

MJFF Publications

2751 - 2760 of 8808 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2022
  • 2023
  • 2023
  • 2022
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: FBXL4 suppresses mitophagy by restricting the accumulation of NIX and BNIP3 mitophagy receptors
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/embj.2022112767
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Modeling of mitochondrial genetic polymorphisms reveals induction of heteroplasmy by pleiotropic disease locus 10398A>G
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-37541-y
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Determinants of coping styles of people with Parkinson’s Disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00548-3
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Frequency of and factors associated with antiseizure medication discontinuation discussions and decisions in patients with epilepsy: A multicenter retrospective chart review
    Journal Name: Epilepsia Open
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/epi4.12695
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2021.110090
    Citation Count: 83
  • Summary Details
    OPEN
    Title: AI reveals insights into link between CD33 and cognitive impairment in Alzheimer’s Disease
    Journal Name: PLOS Computational Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pcbi.1009894
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Novel Green Fluorescent Polyamines to Analyze ATP13A2 and ATP13A3 Activity in the Mammalian Polyamine Transport System
    Journal Name: Biomolecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.3390/biom13020337
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Temporal order of clinical and biomarker changes in familial frontotemporal dementia
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-022-01942-9
    Citation Count: 98
  • Summary Details
    OPEN
    Title: Childhood Trauma and Parkinson Disease
    Journal Name: Neurology Clinical Practice
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/cpj.0000000000200124
    Citation Count: 7
  • Summary Details
    OPEN
    Title: A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00473-5
    Citation Count: 30
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.